BDX vs SOLV
BDX: A global medical technology leader providing essential healthcare supplies, diagnostic systems, and biosciences research tools to improve patient outcomes. SOLV: A diversified healthcare technology and medical products provider focused on improving patient outcomes through specialized clinical tools and healthcare software solutions.
Side-by-side fundamentals
| Metric | BDX | SOLV | Edge |
|---|---|---|---|
| Price as of 2026-08-06 close | $177.07 | $82.96 | |
| Market cap as of 2026-08-08 | $48.8B | $14.1B | |
| P/E as of 2026-08-08 | 42.37 | 9.84 | SOLV lower |
| PEG as of 2026-08-08 | -24.04 | 0.04 | BDX lower |
| Net margin as of 2026-08-08 | +5.3% | +17.3% | SOLV higher |
| Gross margin as of 2026-08-08 | +47.0% | +54.8% | SOLV higher |
| Operating margin as of 2026-08-08 | +10.3% | +23.9% | SOLV higher |
| ROE as of 2026-08-08 | +4.5% | +29.0% | SOLV higher |
| ROA as of 2026-08-08 | +2.1% | +10.1% | SOLV higher |
| Debt / equity as of 2026-08-08 | 0.72 | 1.10 | BDX lower |
| Revenue growth (YoY) as of 2026-08-08 | +2.4% | -0.9% | BDX higher |
| Revenue CAGR (3y) SEC XBRL | +5.0% | +0.8% | BDX higher |
| Dividend yield as of 2026-08-08 | +2.4% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-08 | 0.21 | 0.58 | |
| 1-year return as of 2026-08-06 close | +30.6% | +14.3% | BDX higher |
Fundamentals: market data, as of 2026-08-08. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-06.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.